Corporate Finance
ev3 Inc.
ev3 Inc. reported revenue results for the first quarter of 2008. For the quarter,the company reported preliminary revenue of approximately $101.3 million.
SemBioSys Genetics Inc.
SemBioSys Genetics Inc. announced that it has received milestone payments totaling CAD 850,000 from AVAC Ltd.
CardioDynamics International Corp.
CardioDynamics International Corp announced earnings results for the first quarter ended February 29, 2008.
Neose Technologies Inc.
Neose Technologies Inc. announced that on March 12, 2008, it has entered into a Commercial Insurance Premium Finance and Security Agreement with Cananwill Inc. to finance the insurance policy premiums due on certain insurance policies of the Company. The amount financed under the Finance Agreement is $370,622.96 and, pursuant to its terms, the Company is required to make a payment of $34,391.04 during each of the 11 months beginning on March 15, 2008 and ending on January 15, 2009.
Angiotech Pharmaceuticals Inc
Angiotech Pharmaceuticals Inc. announced the filing of its audited consolidated financial statements and Management's Discussion and Analysis for the year ended December 31, 2007 and the restatement of its audited consolidated financial statements for the year ended December 31, 2006. For the year ended December 31, 2007, the Company's net loss according to GAAP was $65.9 million, as compared to $59.4 million reported in the preliminary results announced on February 14, 2008.
MEDSEEK
ev3 Inc.
SemBioSys Genetics Inc
SemBioSys Genetics Inc. announced that it has received milestone payments totaling CAD 850,000 from AVAC Ltd.
CardioDynamics International Corp
Neose Technologies Inc.
Neose Technologies Inc. announced that on March 12, 2008, it has entered into a Commercial Insurance Premium Finance and Security Agreement with Cananwill Inc. to finance the insurance policy premiums due on certain insurance policies of the Company.
